Infectious Diseases – Products

Product News
HORIBA UK Expands POCKIT Central In-House Veterinary PCR Range
Visitors to London Vet Show can see how new reagent pack sizes make rapid point-of-care PCR more accessible.

Product News
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.

Product News
Armis Biopharma Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds
Armis Biopharma, Inc. announced that the company received a $20.3 million contract from the Defense Threat Reduction Agency (DTRA) to develop its proprietary Veriox® DECON chemical warfare agent (CWA) decontamination product.

Product News
Oxford Nanopore Technologies and Fabric Genomics Collaborate To Launch an Integrated Whole-Genome Sequencing Solution
The partners will offer an integrated sample-to-report rapid nanopore sequencing analysis platform for neonatal/paediatric intensive care units to support clinicians in acute settings.

Product News
Oxford Nanopore Meets Apple’s M3 Silicon Chip
CEO Gordon Sanghera discusses how Apple’s latest product announcement means complex processing required for DNA/RNA sequencing can now be run from the latest MacBook Pro™ or iMac ™.

Product
Advertisement
Applied Biosystems TaqPath COVID-19, Flu A/B, RSV Combo Kit: Multiplex PCR Test
Because RSV, influenza, and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. The CE-IVD marked multiplex TaqPath COVID-19, Flu A/B, RSV Combo Kit is specifically designed to detect and differentiate between these three viruses during flu season

Product News
bioMérieux Makes Strategic Investment in Oxford Nanopore
Oxford Nanopore Technologies, announce that bioMérieux is making an immediate £70M investment in Oxford Nanopore.

Product News
Gates Foundation To Accelerate mRNA Vaccine Innovation and Manufacturing in Africa and Globally
At the 2023 Grand Challenges Annual Meeting, Bill Gates, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries.

Product News
Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies
Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.

Product News
Evonetix Places First DNA Synthesis Development Platform at Imperial College London
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization.
Advertisement